Subburayan Karthikeyan

658 citations
7 papers · 550 indexed · h-index 7
Topics
Bioactive Compounds and Antitumor Agents (2 papers)Drug Transport and Resistance Mechanisms (2 papers)Sirtuins and Resveratrol in Medicine (2 papers)
Partner nations
IndiaAustraliaOman

In The Last Decade

Subburayan Karthikeyan

7 papers receiving 540 citations

Peers

Subburayan Karthikeyan
Comparison fields: 5 of 85
  • Molecular Biology 240
  • Oncology 104
  • Biochemistry 75
  • Pharmacology 63
  • Complementary and alternative medicine 62
Replace Reza Entezari Heravi with:
Reza Entezari Heravi Iran
Asma Ismail Mahmod Jordan
Zeinab Nouri Iran
Akhilendra Kumar Maurya India
Mohd Fahad Ullah India
Kalle M. Arunasree India
Yi‐Shih Ma Taiwan
Kanokkarn Phromnoi Thailand
Mohammed Kaleem Saudi Arabia
Sahar Behzad Iran
Subburayan Karthikeyan relative to Reza Entezari Heravi Iran Reza Entezari Heravi's profile →
Citations per field
00.5×10×14.7×
Reza Entezari Heravi · 1×
Citations per year

Countries citing papers authored by Subburayan Karthikeyan

Since Specialization
Citations

This map shows the geographic impact of Subburayan Karthikeyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subburayan Karthikeyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subburayan Karthikeyan more than expected).

Fields of papers citing papers by Subburayan Karthikeyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subburayan Karthikeyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subburayan Karthikeyan. The network helps show where Subburayan Karthikeyan may publish in the future.

Co-authorship network of co-authors of Subburayan Karthikeyan

This figure shows the co-authorship network connecting the top 25 collaborators of Subburayan Karthikeyan. A scholar is included among the top collaborators of Subburayan Karthikeyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subburayan Karthikeyan. Subburayan Karthikeyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 23
2 81
3 99
4 12
5 148
6 91
7 96

About Subburayan Karthikeyan

Subburayan Karthikeyan is a scholar working on Toxicology, Geriatrics and Gerontology and Molecular Medicine, having authored 7 papers that have together received 550 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Biochemistry (75 citations), Molecular Medicine (54 citations) and Geriatrics and Gerontology (34 citations). Subburayan Karthikeyan has collaborated with scholars based in India, Australia and Oman. Frequent co-authors include N. Rajendra Prasad, S. L. Hoti, N. Krishnakumar, Rajendran Mahalakshmi, Nady Braidy, Thamilarasan Manivasagam, Musthafa Mohamed Essa, Arokiasamy Justin Thenmozhi, Selvaraju Subash and Gilles J. Guillemin. Their work appears in journals such as Oncotarget, Oxidative Medicine and Cellular Longevity and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026